Regulatory Expertise

UK Cosmetic Compliance

Placing cosmetics on the Great Britain market: the assimilated UK Cosmetics Regulation, OPSS enforcement, a GB-based Responsible Person, the CPSR and PIF, SCPN notification, and the divergence from the EU under SI 2026/23. Cosmetics are not UKCA-marked.

Great Britain runs its own cosmetic regime, separate from the EU since Brexit and now diverging from it in substance. Selling a cosmetic in England, Scotland or Wales means meeting the UK Cosmetics Regulation, the version of Regulation (EC) No 1223/2009 assimilated into domestic law by Schedule 34 of the Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019, enforced by the Office for Product Safety and Standards (OPSS) and local Trading Standards under the Cosmetic Products Enforcement Regulations 2013. The structure still mirrors the EU Regulation, the same articles and the same annexes, but the two are no longer identical and the gap is widening.

The Responsible Person

Every cosmetic on the GB market must have a Responsible Person established in the United Kingdom (Article 4). The role can sit with the manufacturer, the importer or a distributor, or it can be delegated to a third party by written mandate, but the address must be in the UK. The Responsible Person holds the legal obligations set out in Article 5: ensuring a compliant safety assessment is in place, holding and maintaining the Product Information File, making the SCPN notification, ensuring the labelling and claims comply, operating cosmetovigilance, and taking corrective action and notifying OPSS where a product is non-compliant or presents a risk. A GB distributor importing from outside Great Britain becomes the Responsible Person unless another UK entity takes the role. Oxford Biosciences acts as UK Responsible Person, and as EU Responsible Person, under a single quality management system.

The Cosmetic Product Safety Report

Safety is substantiated through a Cosmetic Product Safety Report under Article 10 and Annex I. Part A assembles the safety information: the quantitative and qualitative composition, the physico-chemical characteristics and stability, the microbiological quality, the impurities and traces, information on the packaging material, normal and reasonably foreseeable use, exposure to the product and to each substance, the toxicological profile of the ingredients, and any undesirable effects. Part B is the assessor’s reasoned conclusion on safety, the labelled warnings and the reasoning behind them. Annex I requires the assessment to be carried out by a person holding a qualification in pharmacy, toxicology, medicine or a similar discipline; ours are prepared and signed by a Clinical Pharmacologist.

The Product Information File

The Responsible Person keeps a Product Information File under Article 11, holding the product description, the safety report, a description of the manufacturing method with a statement of compliance with good manufacturing practice, proof of the claimed effect where the nature of the claim justifies it, and data on any animal testing. It must be kept in English, held readily accessible at the address shown on the label, and retained for ten years after the last batch was placed on the market, available to OPSS on request.

Notification through SCPN

Before a product is sold it is notified through the Submit Cosmetic Product Notification (SCPN) portal, the GB counterpart to the EU’s CPNP. The notification covers the product category and name, the Responsible Person’s details, the frame formulation, the presence of any CMR substances and nanomaterials, and the label and product image, so that OPSS and the poisons services hold what they need. SCPN and CPNP are separate systems: a CPNP notification does not cover Great Britain, and an SCPN notification does not cover the EU.

Labelling

Article 19 sets the mandatory label elements: the Responsible Person’s name and UK address, the nominal content, the date of minimum durability or the period-after-opening symbol, precautions for use, the batch number, the product function, and the list of ingredients by INCI name in descending order of weight. The defining GB requirement is the address, which must be that of the UK Responsible Person. A post-Brexit easement that allowed an EU Responsible Person address to remain on GB-market packs has been winding down, so UK Responsible Person details on pack are now expected rather than optional.

Cosmetics are not UKCA-marked

Cosmetics do not carry UKCA or CE marking. Those marks belong to other product families, such as electronics, toys and medical devices, that demonstrate conformity through a marking regime. A cosmetic demonstrates compliance through its safety report, its SCPN notification and its Responsible Person, not a conformity mark, so a request for a “UKCA certificate” on a cosmetic is a category error rather than a missing document.

Divergence and the 2026 changes

The clearest sign that the two regimes have parted is SI 2026/23, the Cosmetic Products (Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026, laid on 15 January 2026 on the advice of the Scientific Advisory Group on Chemical Safety. It removes the UV filter 4-methylbenzylidene camphor (4-MBC) from the permitted UV-filter list in Annex VI and prohibits it in Annex II: it cannot be placed on the GB market from 15 July 2026, with a sell-through to 14 January 2027. It adds sixteen substances newly classified as carcinogenic, mutagenic or reprotoxic to the prohibited list from 15 August 2026, with a sell-through to 14 February 2027, the cosmetically significant one being trimethylbenzoyl diphenylphosphine oxide (TPO), used in gel and nail products. And it lowers the threshold at which a formaldehyde-releasing substance must carry a consumer warning to 0.001 per cent. None of this applies in Northern Ireland, which follows the EU regime under the Windsor Framework, so a product sold across the whole United Kingdom can face two different sets of annexes at once. Further reviews, PFAS among them, are expected, so the divergence will grow rather than settle.

How we help

We act as your UK Responsible Person, prepare and sign the CPSR, compile and hold the Product Information File, make the SCPN notification, and review labelling and claims against Article 19 and the Common Criteria. Because the GB and EU annexes are now moving apart, we keep each assessment current against the GB position and flag where a product sold in both Great Britain and the EU or Northern Ireland needs checking against both, against the 2026 dates in particular.

Relevant services

👤

Responsible Person

From £149 · per product, per year

Oxford Biosciences acts as your Responsible Person in the UK and the EU under a single quality management system, holding the regulatory obligation: PIF maintenance, SCPN and CPNP notification, labelling oversight, and cosmetovigilance.

Learn more →
📋

CPSR

From £70 · 2 to 3 days

The Cosmetic Product Safety Report is the safety assessment required under Article 10 and Annex I of Regulation (EC) No 1223/2009 before a cosmetic product may be placed on the UK or EU market. Prepared and signed by a qualified safety assessor.

Learn more →
🏷️

Labelling

From £195 · from receipt of artwork

Independent review of packaging artwork against Article 19, and of product claims against the six Common Criteria of Regulation (EU) 655/2013. Label review £195; per-claim review from £125; substantiation dossiers from £1,495.

Learn more →

Frequently asked questions

What are the UK Responsible Person requirements?

To sell a cosmetic product in Great Britain you must appoint a UK Responsible Person established in the UK, who takes legal responsibility for compliance, holds the Product Information File, and notifies the product through the SCPN service to the Office for Product Safety and Standards. Since 1 January 2026 the UK Responsible Person's name and address must appear on the product label for goods placed on the GB market. Oxford Biosciences acts as UK Responsible Person through Oxford Biosciences Ltd, and as EU Responsible Person through our Irish-registered entity, under a single quality management system.

What is SCPN?

SCPN, the Submit Cosmetic Product Notification service, is the UK government system through which cosmetic products are notified before being placed on the Great Britain market. It replaced reliance on the EU's CPNP for GB after Brexit. Notification is made by the UK Responsible Person and is overseen by the Office for Product Safety and Standards (OPSS). A product should be notified only once it has been assessed as safe. Oxford Biosciences manages SCPN notification as part of its UK Responsible Person service.

How much does a UK CPSR cost?

A UK Cosmetic Product Safety Report from Oxford Biosciences is £220 for a single product of up to 20 ingredients, the same report that serves the EU market under Annex I of Regulation (EC) No 1223/2009. A single-ingredient product is £70, variants are £40, and batch pricing applies from £875 for five products. Once the full documentation set is supplied, turnaround is typically 2 to 3 working days, with 48-hour and 24-hour expedited service available. All fees are exclusive of VAT.

Do cosmetics need a CE or UKCA mark?

No. Cosmetics do not carry CE or UKCA marks. Those conformity marks apply to other product groups such as electronics, toys, machinery, personal protective equipment and medical devices, not to cosmetics. In the EU a cosmetic demonstrates compliance through a Cosmetic Product Safety Report under Regulation (EC) No 1223/2009, notification on the CPNP, and an EU Responsible Person. In Great Britain it is the same evidence under the UK Cosmetics Regulation, notified through the SCPN with a UK-based Responsible Person. If a supplier or manufacturer tells you a cosmetic needs a CE or UKCA mark, they have confused cosmetics with a different product category. Oxford Biosciences prepares the safety report, notification and Responsible Person designation that actually establish cosmetic compliance.

What is changing for cosmetics in Great Britain in 2026?

SI 2026/23 bans the UV filter 4-MBC from 15 July 2026, adds sixteen CMR-classified substances to the prohibited list from 15 August 2026, and lowers the labelling threshold for formaldehyde-releasing substances to 0.001 per cent. Northern Ireland is unaffected, as it follows the EU regime.

Do cosmetics sold in Northern Ireland follow UK or EU rules?

EU rules. Under the Windsor Framework, cosmetics placed on the Northern Ireland market follow the EU Cosmetics Regulation, while Great Britain follows the assimilated UK regime, so a product sold across the whole UK may need to meet two diverging sets of requirements.

Get a quote →
TALK TO US
Questions about CPSRs, MoCRA or Labelling? Ask us anything!